software based scoring and report including insight of the affinity of binary interactions.

The global nanomedicine market, valued at USD 195 billion in 2025, is projected to grow at a CAGR of 15–20% if key industry challenges are resolved, reaching USD 392–485 billion by 2030. This report outlines the market forecast, key growth barriers, competitive landscape, and the strategic positioning.

The global lab-on-a-chip (LoC) and point-of-care diagnostics (POCD) markets are undergoing rapid transformation, driven by the convergence of AI, nanotechnology, and microfluidics. This report provides a comprehensive analysis of the market landscape, including size, growth potential, key challenges, competitive dynamics, and recent developments.

AI avatars used for : • real-time clinical communication and reasoning • decision-making under pressure • conflict management and de-escalation • bias mitigation

Flexible accessibility via: • browser-based and desktop apps • VR/MR headsets • learning management systems (LMS) • holographic boxes, totems, and interactive projections in phygital spaces.

*contact us for further details

VR-based therapy system designed to treat visual conditions (e.g., amblyopia, vergences, and oculomotor skills). Home-based therapy.

Accessible via a mobile app and compatible VR headset. Suitable for for children from age four​​. VR headset+gamepad (mobile not included)

*If interested in home-based herapy sessions provided by specialists, please contact us.
*Fee-per-year, unlimitted number of users.

Portable virtual reality-based tool for optometric testing.
It offers tests like visual field and contrast sensitivity.
Supports remote exams, transforming commercial VR devices into portable optometry suites, connecting patients and specialists regardless of their location.

*Contact for renting options.

The global rare disease treatment market demonstrates exceptional growth potential, with the complement inhibitors submarket leading the charge at an even more impressive 13.1% CAGR (2025–2032). This acceleration is driven by rising prevalence of complement-mediated diseases and robust pipeline innovation.

Screening of Hereditary Hemorrhagic Telangiectasia (HHT).

Also known as: HHT, Osler-Weber Rendu syndrome, Rendu-Osler-Weber syndrome.

Identify and monitor any of these diseases from a small saliva sample (please, contact us for further details, since trained handling may apply)

*For Research Use Only.